Screener
Madrigal Pharmaceuticals, Inc. MDGL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total assets | $1,244,645 | $1,259,589 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $34,514 | $48,878 |
| Accrued liabilities | 338,656 | 260,392 |
| Operating lease liabilities | 1,034 | 1,018 |
| Total current liabilities | 374,204 | 310,288 |
| Long term liabilities: |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s accounts payable?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported accounts payable of $34.51M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s accounts payable decreased by 9.1% year-over-year, from $37.98M to $34.51M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s accounts payable has grown at a 116.9% compound annual growth rate (CAGR), from $1.02M to $48.88M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude